314 related articles for article (PubMed ID: 25869896)
21. Vaccine and skin testing properties of two avirulent Mycobacterium bovis mutants with and without an additional esat-6 mutation.
Collins DM; Kawakami RP; Wards BJ; Campbell S; de Lisle GW
Tuberculosis (Edinb); 2003; 83(6):361-6. PubMed ID: 14623166
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.
Demangel C; Garnier T; Rosenkrands I; Cole ST
Infect Immun; 2005 Apr; 73(4):2190-6. PubMed ID: 15784562
[TBL] [Abstract][Full Text] [Related]
23. A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen.
Chiwala G; Liu Z; Mugweru JN; Wang B; Khan SA; Bate PNN; Yusuf B; Hameed HMA; Fang C; Tan Y; Guan P; Hu J; Tan S; Liu J; Zhong N; Zhang T
Biomed Pharmacother; 2021 Oct; 142():112047. PubMed ID: 34426260
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and protective efficacy conferred by a novel recombinant Mycobacterium bovis bacillus Calmette-Guérin strain expressing interleukin-12p70 of human cytokine and Ag85A of Mycobacterium tuberculosis fusion protein.
Deng YH; He HY; Zhang FJ
Scand J Immunol; 2013 Dec; 78(6):497-506. PubMed ID: 24283772
[TBL] [Abstract][Full Text] [Related]
25. Pathogenomic analyses of
Orgeur M; Frigui W; Pawlik A; Clark S; Williams A; Ates LS; Ma L; Bouchier C; Parkhill J; Brodin P; Brosch R
Microb Genom; 2021 Feb; 7(2):. PubMed ID: 33529148
[No Abstract] [Full Text] [Related]
26. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis.
Horwitz MA; Harth G
Infect Immun; 2003 Apr; 71(4):1672-9. PubMed ID: 12654780
[TBL] [Abstract][Full Text] [Related]
27. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
[TBL] [Abstract][Full Text] [Related]
28. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and Rv2608 elicits significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Lu Y; Xu Y; Yang E; Wang C; Wang H; Shen H
Scand J Immunol; 2012 Sep; 76(3):271-7. PubMed ID: 22671973
[TBL] [Abstract][Full Text] [Related]
29. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
30. Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.
Sali M; Di Sante G; Cascioferro A; Zumbo A; Nicolò C; Donà V; Rocca S; Procoli A; Morandi M; Ria F; Palù G; Fadda G; Manganelli R; Delogu G
Infect Immun; 2010 Dec; 78(12):5202-13. PubMed ID: 20921146
[TBL] [Abstract][Full Text] [Related]
31. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
32. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
[TBL] [Abstract][Full Text] [Related]
33. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.
Villarreal DO; Walters J; Laddy DJ; Yan J; Weiner DB
Hum Vaccin Immunother; 2014; 10(8):2188-98. PubMed ID: 25424922
[TBL] [Abstract][Full Text] [Related]
34. Subunit vaccine candidate AMM down-regulated the regulatory T cells and enhanced the protective immunity of BCG on a suitable schedule.
Luo Y; Jiang W; Da Z; Wang B; Hu L; Zhang Y; An R; Yu H; Sun H; Tang K; Tang Z; Wang Y; Jing T; Zhu B
Scand J Immunol; 2012 Mar; 75(3):293-300. PubMed ID: 22117839
[TBL] [Abstract][Full Text] [Related]
35. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
36. Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-alpha induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice.
Shen H; Wang C; Yang E; Xu Y; Liu W; Yan J; Wang F; Wang H
Microbiol Immunol; 2010 Aug; 54(8):435-41. PubMed ID: 20646207
[TBL] [Abstract][Full Text] [Related]
37. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
[TBL] [Abstract][Full Text] [Related]
39. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
[TBL] [Abstract][Full Text] [Related]
40. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
